How to build a peptide website that converts without getting you shut down

Peptides are one of the fastest-growing categories we get asked about, and one of the most dangerous to market carelessly. The businesses that win in this space are not the ones with the boldest claims. They are the ones that are still operating in eighteen months.

This is a practical playbook: what a peptide website needs, in what order, and where the landmines are.

One caveat before anything else. This is marketing guidance, not legal or medical advice. Regulations differ by jurisdiction and change frequently. Have a healthcare-regulatory attorney review your specific claims before you publish them. Nothing below substitutes for that.

Start with the classification question

Everything about your site (copy, structure, checkout, ad eligibility) flows from one question: what are you actually selling, and to whom?

The common models:

• Research-use-only (RUO) chemicals sold to laboratories and institutions.
• Compounded prescriptions dispensed through a licensed pharmacy after a genuine clinical relationship.
• Telehealth platforms connecting patients to licensed providers who may prescribe.
• Dietary supplements containing ingredients lawfully marketed as such.

These are legally distinct businesses that happen to share vocabulary. A site that blurs them (RUO disclaimers in the footer, dosage protocols and before-and-after photos on the product page) is not a hybrid. It is an enforcement target, because the content demonstrates intended use for humans regardless of what the disclaimer says.

Regulators read the whole page. A disclaimer does not neutralize a claim; it sits next to it in the exhibit.

Pick your model. Build the entire site as if that model is the only one.

Architecture that works

A peptide site that performs commercially tends to have five layers:

1. Category pages that carry the search intent. Most volume is at the compound level. Build a durable page per compound with a consistent, factual structure: what it is, mechanism at a high level, what published research examined, purity and testing, handling and storage, and (where lawful) how to obtain it. These pages are the SEO backbone.

2. Product pages built for trust, not persuasion. In this category, buyers are unusually sophisticated and unusually skeptical. What moves them: a certificate of analysis for the specific lot, the testing laboratory's name, purity percentage, storage requirements, shipping conditions, and a clear returns policy. Publish the COA as a real document, not a badge graphic.

3. An evidence library. A properly cited research section (actual studies, actual links, honest characterization of what the study did and in what model) is the single most defensible asset a peptide brand can build. It earns links, it satisfies the sophisticated buyer, and it demonstrates good faith.

4. Compliance infrastructure. Terms, privacy policy, shipping restrictions by jurisdiction, age gating where required, and (critically) disclaimers that match the business model and appear in context rather than only in the footer.

5. Conversion paths appropriate to the model. RUO sellers verify institutional buyers. Telehealth platforms route to intake. Supplement brands sell directly. Do not bolt a consumer checkout onto a research-only catalogue.

The claims problem, concretely

This is where businesses in this category die.

Avoid entirely: claims that a product treats, prevents, cures, or mitigates any disease. That is the line between a supplement or research chemical and an unapproved new drug, and it is not a soft line.

Handle with extreme care: weight-loss claims, anti-aging claims, hormone claims, performance claims, before-and-after imagery, and testimonials. Testimonials are treated as claims. You cannot say through a customer what you cannot say yourself.

Be aware of secondary surfaces. Product titles, meta descriptions, image alt text, blog posts, email flows, affiliate copy, and influencer scripts are all evidence. The most common failure we see is a clean product page undermined by an affiliate writing whatever converts.

Structured data is a claim too. Marking up a research chemical with Product schema, review stars, and consumer pricing is asserting a consumer product. Make the markup match the model.

Technical foundations

The unglamorous work that decides whether any of the above gets seen:

• Speed. These sites are frequently image-heavy: COAs, molecular diagrams, lab photography. Compress, use modern formats, lazy-load below the fold.
• Crawlable content. Compound information rendered by client-side JavaScript is invisible to a meaningful share of the systems that would otherwise cite you.
• Clean information architecture. One canonical page per compound. Not fourteen near-duplicates for every spelling and dosage variant. That is thin-content territory, and it competes with itself.
• Answer-engine readiness. People increasingly ask an AI assistant about compounds before they search. If your pages are legible, well-structured, and factual, you are quotable. If they are marketing copy over a JavaScript shell, you are not in the conversation.

Run your build through a technical grade before launch, not after.

Payments, ads, and the operational reality

Plan for these constraints from day one rather than discovering them at launch:

• Payment processing in this category is restricted at most mainstream providers. Expect to need a high-risk processor and to have your site reviewed as part of underwriting. Your public claims are part of that review.
• Paid advertising is heavily limited. Google and Meta both restrict this space, and enforcement is inconsistent but consequential. Assume organic search, email, and community are your durable channels: build accordingly.
• Email deliverability suffers if your content trips filters. Sending disciplined, non-claim-heavy email from a warmed domain matters more here than in almost any other vertical.

The strategic consequence: channels you own are not a nice-to-have in this category, they are the business. A peptide brand dependent on paid acquisition is one policy update away from zero.

What good looks like

The best-performing peptide sites we have worked on share a profile that is almost boring: rigorous, specific, transparent about testing, careful about claims, fast, and deep on genuine information. They read like a supplier that expects to be scrutinized, because they do.

The ones that flame out share a profile too. Aggressive claims, borrowed stock imagery, a disclaimer doing impossible work at the bottom of the page, and a growth curve that ends abruptly when a processor or a regulator notices.

If you are building in this category and want a partner who will tell you which side of that line your site is on, apply for partnership. And run the free grader first: it takes a minute and tells you what the machines currently see.